HomeInsightsStock Comparison

Alivus Life Sciences Ltd vs Natural Capsules Ltd Stock Comparison

Alivus Life Sciences Ltd vs Natural Capsules Ltd Stock Comparison

Last Updated on: Jun 25, 2025

Key Highlights

  • The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 994.35 as of 24 Jun 15:30.
  • The P/E Ratio of Alivus Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Natural Capsules Ltd changed from 23.8 on March 2020 to 51.3 on March 2024 . This represents a CAGR of 16.60% over 5 years.
  • The Market Cap of Alivus Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Natural Capsules Ltd changed from ₹ 20.47 crore on March 2020 to ₹ 284.77 crore on March 2024 . This represents a CAGR of 69.31% over 5 years.
  • The revenue of Alivus Life Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Natural Capsules Ltd for the Mar '25 is ₹ 45.27 crore as compare to the Dec '24 revenue of ₹ 43.94 crore. This represent the growth of 3.03%.
  • The ebitda of Alivus Life Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Natural Capsules Ltd for the Mar '25 is ₹ 4.69 crore as compare to the Dec '24 ebitda of ₹ 4.38 crore. This represent the growth of 7.08%.
  • The net profit of Alivus Life Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Natural Capsules Ltd changed from ₹ 1.82 crore to ₹ 0.52 crore over 8 quarters. This represents a CAGR of -46.55% .
  • The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 58.56 % on March 2024 . This represents a CAGR of -1.60% over 3 yearsThe Dividend Payout of Natural Capsules Ltd changed from 43.47 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alivus Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

About Natural Capsules Ltd

  • Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore.
  • The Company is one of the leading manufacturers of hard capsule shells in India.
  • The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country. NCL expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry.
  • By venturing into API manufacturing under its subsidiary, Natural Biogenex Private Limited, Company presently operates two distinct business verticals-Capsules and APIs.
  • The company is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form. The Company meets the statutory requirements as laid down by the authorities in respect to cGMP and cGLP practices.

Alivus Life Sciences Ltd News Hub

News

Board of Alivus Life Sciences recommends final dividend

Alivus Life Sciences announced that the Board of Directors of the Company at its meeting h...

Read more

16 May 2025 09:27

News

Alivus Life Sciences to hold board meeting

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

09 May 2025 10:57

News

Alivus Life Sciences allots 92,096 equity shares under ESOS

Alivus Life Sciences has allotted 92,096 equity shares under ESOS on 30 April 2025. Conseq...

Read more

30 Apr 2025 19:38

News

Alivus Life jumps after Q3 PAT climbs 15% YoY to Rs 137 cr

Profit before tax (PBT) climbed 15.22% YoY to Rs 185.14 crore in Q3 FY25. For Q3FY25, EBIT...

Read more

23 Jan 2025 15:01

News

Alivus Life Sciences Ltd leads gainers in 'A' group

Avantel Ltd, Sunteck Realty Ltd, Spandana Sphoorty Financial Ltd and Jai Corp Ltd are amon...

Read more

21 Jan 2025 12:00

News

Glenmark Life Sciences renamed as Alivus Life Sciences

Glenmark Life Sciences announced its change of identity to Alivus Life Sciences, marking a...

Read more

20 Jan 2025 10:18

Natural Capsules Ltd News Hub

News

Natural Capsules declare Quarterly Result

Natural Capsules will hold a meeting of the Board of Directors of the Company on 29 May 20...

Read more

23 May 2025 20:27

News

Natural Capsules schedules board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 Februa...

Read more

06 Feb 2025 13:40

News

Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 Novemb...

Read more

05 Nov 2024 13:47

News

Natural Capsules to hold board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 5 Septemb...

Read more

03 Sep 2024 11:09

News

Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 13 August...

Read more

07 Aug 2024 13:56

News

Natural Capsules schedules EGM

Natural Capsules announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

29 Jul 2024 13:39

SWOT Analysis Of Natural Capsules Ltd

Strength

2

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Natural Capsules Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alivus Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alivus Life Sciences Ltd and Natural Capsules Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or Natural Capsules Ltd?

Market cap of Alivus Life Sciences Ltd is 12,193 Cr while Market cap of Natural Capsules Ltd is 228 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Natural Capsules Ltd?

The stock performance of Alivus Life Sciences Ltd and Natural Capsules Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and Natural Capsules Ltd?

As of June 25, 2025, the Alivus Life Sciences Ltd stock price is INR ₹994.35. On the other hand, Natural Capsules Ltd stock price is INR ₹221.3.

How do dividend payouts of Alivus Life Sciences Ltd and Natural Capsules Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and Natural Capsules Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions